VivoSeq
Nephrology

ESRD

1

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

ESRD is an early-stage landscape with 1 program across 1 company. The most active players are Cipla USA Inc.. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

C

Cipla USA Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved1

Invokana and

McGill University Health Centre/Research Institute of the McGill University Health Centre

Analysis

Trial Status

8

clinical trials

Completed6 · 75%
Active, not recruiting1 · 13%
Recruiting1 · 13%

Clinical Trials

Trial Activity

8 trials

A Prospective, Multicenter, Randomized Controlled Trial of HAHD With pHA130 Cartridge vs. Conventional High-Flux HD for Clearance of Protein-Bound Uremic Toxins and Quality of Life Improvement in Kidney Failure.
Recruiting·CChina-Japan Friendship Hospital·Preclinical·NCT07656168·100 enrolled
Ferric Citrate in ESRD Pilot Project
Active, not recruiting·—·Phase 4·NCT03055598·30 enrolled
Effect of rEPO in FGF23 in ESRD Patients
Completed·UUniversity of Chile·N/A·NCT03803514·60 enrolled
ONSET and OFFSET of Ticagrelor in ESRD
Completed·KKyunghee University Medical Center·Phase 3·NCT02163954·16 enrolled
Plazomicin Study in ESRD Patients Receiving IHD
Completed·CCipla USA Inc.·Phase 1·NCT04699656·6 enrolled
Role of Turmeric on Oxidative Modulation in ESRD Patients
Completed·SShiraz University of Medical Sciences·Phase 1/2·NCT01906840·48 enrolled
Safety and Efficacy of Canagliflozin in Advanced CKD
Completed·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·Approved·NCT05309785·34 enrolled
A Culturally Targeted Transplant Program to Increase Live Donation in Hispanics
Completed·NNorthwestern University·Preclinical·NCT03276390·11,836 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)